News
Form 8.3 - The Vanguard Group, Inc.: Clipper Logistics plc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc
NORNICKEL ANNOUNCES CONSOLIDATED PRODUCTION RESULTS FOR 1Q 2022
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Eros Enters Into a New Era of Global Media and Entertainment
Eros STX Global Corporation (“ErosSTX”, “Eros" or the “Company”) (NYSE: ESGC), a global Indian entertainment company, today announced significant corporate developments as follows:
Key Highlights
Kantar to Acquire Blackwood Seven, Accelerating Marketing ROI Technology Roadmap
Kantar, the world’s leading data-driven analytics and brand consulting company today announces it has reached a definitive agreement to acquire Blackwood Seven, the Copenhagen, Denmark-based
Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration
Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with
The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Workspace Group plc
Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc
US Foods Sends Letter to Shareholders Highlighting Strong Preliminary First Quarter 2022 Results and Highly Qualified Board Nominees
US Foods Holding Corp. (NYSE: USFD) (“US Foods” or the “Company”), one of the largest foodservice distributors in the United States, today announced that it has sent a letter to shareholders in
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Aroundtown SA: Release of a capital market information
Poxel Announces Its Participation in Upcoming Scientific Conferences
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Technip Energies First Quarter 2022 Financial Results
Regulatory News:
Technip Energies (PARIS:TE) (the “Company”), a leading Engineering & Technology company for the energy transition, today announces its unaudited financial results for the first
PJSC Magnitogorsk Iron and Steel Works: MMK notifies about actions under newly introduced regulations for depositary receipts programmes of Russian issuers